← Leaderboards
Jon-Kar Zubieta
University Of Michigan At Ann Arbor
$15,880,746
Attributed
$18,540,048
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$18,540,048 · 19
By mechanism
R01$13,837,211 · 9
R21$2,139,926 · 3
R33$1,646,713 · 1
R61$830,946 · 1
M01$85,252 · 5
Top collaborators
- Mark K. Greenwald5 shared
- Scott James Peltier5 shared
- Julie A Blendy3 shared
- Caryn Lerman3 shared
- Lee-Yuan Liu-Chen3 shared
- Eric Lee Garland2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Scott A Langenecker$11,875,326
- Michael R Kilbourn$3,886,582
- Cynthia Anne Chestek$14,384,520
- Subramaniam Pennathur$11,719,201
- Denise Cortis Park$27,156,906
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainAffectVariantResponseSamplingNeurobiologyPlacebosNeurotransmittersPainPositron-Emission TomographyRadiotracerRegulationStressNeurotransmissionMediatingEndogenous OpiatesOpioid ReceptorResearch StudyAnteriorPharmaceutical PreparationsRewardsBaseAcuteAffective
Grant awards (57)
Neurobiology of Placebo Effects in Fibromyalgia$600,105
R01 · FY2018 · AT · contact PI
Neurobiology of non-specific and specific treatment responses in Major Depression$566,562
R01 · FY2018 · MH · contact PI
Neurobiology of Placebo Effects in Fibromyalgia$596,494
R01 · FY2017 · AT · contact PI
Neurobiology of non-specific and specific treatment responses in Major Depression$562,999
R01 · FY2017 · MH · contact PI
Effects of Mindfulness-Oriented Intervention on Endogenous Opioid Mechanisms of Hedonic Regulation in Chronic Pain.$416,160
R61 · FY2017 · AT
Neurobiology of non-specific and specific treatment responses in Major Depression$623,663
R01 · FY2016 · MH · contact PI
Effects of Mindfulness-Oriented Intervention on Endogenous Opioid Mechanisms of Hedonic Regulation in Chronic Pain.$414,786
R61 · FY2016 · AT
Neurobiology of Placebo Effects in Fibromyalgia$1
R01 · FY2016 · AT · contact PI
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$493,243
R01 · FY2014 · DA · contact PI
Neurobiology of Placebo Effects in Fibromyalgia$186,560
R01 · FY2014 · AT · contact PI
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$474,766
R01 · FY2013 · DA · contact PI
Development and Use of rtfMRI for Self-control of Nicotine Craving$533,133
R33 · FY2012 · DA · contact PI
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$494,902
R01 · FY2012 · DA · contact PI
Stress and Reproductive Hormones in Depression$450,602
R01 · FY2012 · MH · contact PI
Neurochemistry of Opiate Abuse Risk in Chronic Pain$411,896
R01 · FY2012 · DA · contact PI
Predicting Placebo Responses Across Disease States$305,494
R01 · FY2012 · MH · contact PI
Development and Use of rtfMRI for Self-control of Nicotine Craving$550,907
R33 · FY2011 · DA · contact PI
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$495,199
R01 · FY2011 · DA · contact PI
Stress and Reproductive Hormones in Depression$451,911
R01 · FY2011 · MH · contact PI
Neurochemistry of Opiate Abuse Risk in Chronic Pain$417,863
R01 · FY2011 · DA · contact PI
Predicting Placebo Responses Across Disease States$305,794
R01 · FY2011 · MH · contact PI
Development and Use of rtfMRI for Self-control of Nicotine Craving$562,673
R33 · FY2010 · DA · contact PI
Functional Characterization of OPRM1 A118G in Nicotine Dependence$466,343
R21 · FY2010 · DA
Stress and Reproductive Hormones in Depression$457,847
R01 · FY2010 · MH · contact PI
Neurochemistry of Opiate Abuse Risk in Chronic Pain$423,741
R01 · FY2010 · DA · contact PI
Predicting Placebo Responses Across Disease States$314,642
R01 · FY2010 · MH · contact PI
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$132,841
R01 · FY2010 · DA · contact PI
Functional Characterization of OPRM1 A118G in Nicotine Dependence$65,178
R21 · FY2010 · DA
Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels$525,646
R01 · FY2009 · DA · contact PI
Functional Characterization of OPRM1 A118G in Nicotine Dependence$494,557
R21 · FY2009 · DA
Stress and Reproductive Hormones in Depression$452,664
R01 · FY2009 · MH · contact PI
Predicting Placebo Responses Across Disease States$316,595
R01 · FY2009 · MH · contact PI
Development and Use of rtfMRI for Self-control of Nicotine Craving$276,462
R21 · FY2009 · DA · contact PI
Development and Use of rtfMRI for Self-control of Nicotine Craving$288,231
R21 · FY2008 · DA · contact PI
Neurochemistry of Opiate Abuse Risk in Chronic Pain$430,508
R01 · FY2007 · DA · contact PI
Neurochemical Endophenotype Responses to Pain-Stress$345,908
R01 · FY2007 · DA · contact PI
DISTRIBUTION & QUANTIFICATION OF SEROTONIN 1A RECEPTORS IN HEALTHY HUMAN SUBJS$3,614
M01 · FY2007 · RR · contact PI
DIST & QUANTIF OF SEROTONIN 1A RECEPTORS IN DEPRESSED SUBJECTS W/PET$2,486
M01 · FY2007 · RR · contact PI
Neurochemistry of Opiate Abuse Risk in Chronic Pain$484,741
R01 · FY2006 · DA · contact PI
Neurochemical Endophenotype Responses to Pain-Stress$342,627
R01 · FY2006 · DA · contact PI
Neurochemical mediation of placebo responses in humans$304,538
R01 · FY2006 · AT · contact PI
Mu Opioid Mediated Stress Regulation in BPD$179,964
R21 · FY2006 · MH · contact PI
DIST & QUANTIF OF SEROTONIN 1A RECEPTORS IN DEPRESSED SUBJECTS W/PET$15,840
M01 · FY2006 · RR · contact PI
DISTRIBUTION & QUANTIFICATION OF SEROTONIN 1A RECEPTORS IN HEALTHY HUMAN SUBJS$6,132
M01 · FY2006 · RR · contact PI
Neurochemical Endophenotype Responses to Pain-Stress$344,795
R01 · FY2005 · DA
Neurochemical mediation of placebo responses in humans$311,867
R01 · FY2005 · AT
Mu Opioid Mediated Stress Regulation in BPD$184,497
R21 · FY2005 · MH
DIST &QUANTIF OF SEROTONIN 1A RECEPTORS IN DEPRESSED SUBJECTS W/PET$29,335
M01 · FY2005 · RR
DISTRIBUTION &QUANTIFICATION OF SEROTONIN 1A RECEPTORS IN HEALTHY HUMAN SUBJS$15,439
M01 · FY2005 · RR
Neurochemical Endophenotype Responses to Pain-Stress$359,214
R01 · FY2004 · DA
Neurochemical mediation of placebo responses in humans$311,867
R01 · FY2004 · AT
Mu Opioid Mediated Stress Regulation in BPD$184,694
R21 · FY2004 · MH
Distribution &Quantification of Serotonin 1A Receptors in Healthy Human Subjs.$8,642
M01 · FY2004 · RR
Dist. &Quantif. of Serotonin 1A Receptors in Depressed Subjects w/PET$3,558
M01 · FY2004 · RR
Neurochemical mediation of placebo responses in humans$308,438
R01 · FY2003 · AT
SEX DIFFERENCES--N REGIONAL U OPIOID RECEPTOR PAIN PROC$230,678
R01 · FY2000 · DE
QUANTIFICATION OF VESICULAR AMINE TRANSPORTER SITES IN BIPOLAR DISORDER PATIENTS$206
M01 · FY2000 · RR